Pathological outcomes associated with the 17q prostate cancer risk variants.

doi:10.1016/j.juro.2009.01.109

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Pathological outcomes associated with the 17q prostate cancer risk variants.

The Journal of urology - 1 Jun 2009

Helfand Brian T, Loeb Stacy, Meeks Joshua J, Fought Angela J, Kan Donghui, Catalona William J

Abstract excerpt

PURPOSE: Recent studies have identified 2 distinct genetic variants along chromosome 17, including allele T of single nucleotide polymorphism rs4430796 on 17q12 and allele G of single nucleotide polymorphism rs1859962 on 17q24, that have been linked to prostate cancer risk. Less is known about tumor pathological features in carriers of these variants. MATERIALS AND METHODS: Genotypes for regions 17q12 and 17q24...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged

Share to Aged, 80 and over

Share to Case-Control Studies

Share to Chromosomes, Human, Pair 17

Share to Genotype

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 19371897
DOI: 10.1016/j.juro.2009.01.109
PMCID: PMC3140699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathological outcomes associated with the 17q prostate cancer risk variants.PMID 19371897Read ↗

Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.Semantic proximity Read ↗

Association between single nucleotide polymorphisms on chromosome 17q and the risk of prostate cancer in a Chinese population.Semantic proximity Read ↗

Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.Semantic proximity Read ↗

Association of 17q24 rs1859962 gene polymorphism with prostate cancer risk: A systematic review and meta-analysis.Semantic proximity Read ↗

Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.Semantic proximity Read ↗

Association of a single-nucleotide polymorphism from chromosome 17q12 with the aggressiveness of prostate cancer in a Hispanic population.Semantic proximity Read ↗

Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.Semantic proximity Read ↗

Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles.Semantic proximity Read ↗

CYP17 polymorphisms and prostate cancer outcomes.Semantic proximity Read ↗

Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?Semantic proximity Read ↗

Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans.Semantic proximity Read ↗

The impact of germline genetic variations in hydroxysteroid (17-beta) dehydrogenases on prostate cancer outcomes after prostatectomy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.